Nonlinear dynamics of CAR-T cell therapy

被引:0
|
作者
Fassoni, Artur C. [1 ,2 ]
Braga, Denis C. [1 ]
机构
[1] Univ Fed Itajuba, Inst Matemat & Computacao, BR-37500903 Itajuba, Brazil
[2] Tech Univ Dresden, Inst Med Informat & Biometry, Dresden, Germany
关键词
Nonlinear phenomena; Differential equations; Hopf bifurcation; Bogdanov-Takens bifurcation; Mathematical oncology; Immunotherapy; MODELS; PROLIFERATION; BIFURCATIONS; OSCILLATIONS;
D O I
10.1016/j.chaos.2024.115871
中图分类号
O1 [数学];
学科分类号
0701 ; 070101 ;
摘要
Chimeric antigen receptor T-cell (CAR-T) therapy is considered a promising cancer treatment. The dynamic response to this therapy can be broadly divided into a short-term phase, ranging from weeks to months, and a long-term phase, ranging from months to years. While the short-term response, encompassing the multiphasic kinetics of CAR-T cells, is better understood, the mechanisms underlying the outcomes of the long-term response, characterized by sustained remission, relapse, or disease progression, remain less understood due to limited clinical data. Here, we analyze the long-term dynamics of a previously validated mathematical model of CAR-T cell therapy. We perform a comprehensive stability and bifurcation analysis, examining model equilibria and their dynamics over the entire parameter space. Our results show that therapy failure results from a combination of insufficient CAR-T cell proliferation and increased tumor immunosuppression. By combining different techniques of nonlinear dynamics, we identify Hopf and Bogdanov-Takens bifurcations, which allow to elucidate the mechanisms behind oscillatory remissions and transitions to tumor escape. In particular, rapid expansion of CAR-T cells leads to oscillatory tumor control, while increased tumor immunosuppression destabilizes these oscillations, resulting in transient remissions followed by relapse. Our study highlights different mathematical tools to study nonlinear models and provides critical insights into the nonlinear dynamics of CAR-T therapy arising from the complex interplay between CAR-T cells and tumor cells.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Gut microbiome and CAR-T therapy
    Muhammad Bilal Abid
    Nirav N. Shah
    Theresa C. Maatman
    Parameswaran N. Hari
    Experimental Hematology & Oncology, 8
  • [32] Gut microbiome and CAR-T therapy
    Abid, Muhammad Bilal
    Shah, Nirav N.
    Maatman, Theresa C.
    Hari, Parameswaran N.
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2019, 8 (01)
  • [33] Successful treatment of second-time CAR-T 19 therapy after failure of first-time CAR-T 19 and ibrutinib therapy in relapsed mantle cell lymphoma
    Mu, Juan
    Liu, Meijing
    Wang, Jia
    Meng, Juanxia
    Zhang, Rui
    Jiang, Yanyu
    Deng, Qi
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 31 (03): : 327 - 335
  • [34] Advances in CAR-T Cell Therapy in Head and Neck Squamous Cell Carcinoma
    Wang, Han-Qi
    Fu, Ruxing
    Man, Qi-Wen
    Yang, Guang
    Liu, Bing
    Bu, Lin-Lin
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [35] Multifaceted Role of the Transforming Growth Factor β on Effector T Cells and the Implication for CAR-T Cell Therapy
    de Folmont, Apolline
    Bourhis, Jean-Henri
    Chouaib, Salem
    Terry, Stephane
    IMMUNO, 2021, 1 (03): : 160 - 173
  • [36] CAR-T Cells in the Treatment of Ovarian Cancer: A Promising Cell Therapy
    Zhang, Xi-Wen
    Wu, Yi-Shi
    Xu, Tian-Min
    Cui, Man-Hua
    BIOMOLECULES, 2023, 13 (03)
  • [37] Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
    Wang, Hao
    Kaur, Gurbakhash
    Sankin, Alexander I.
    Chen, Fuxiang
    Guan, Fangxia
    Zang, Xingxing
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
  • [38] Novel technologies for improving the safety and efficacy of CAR-T cell therapy
    Keisuke Ohta
    Yukimi Sakoda
    Koji Tamada
    International Journal of Hematology, 2023, 117 : 647 - 651
  • [39] Current status and future challenges of CAR-T cell therapy for osteosarcoma
    Li, Shizhe
    Zhang, He
    Shang, Guanning
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [40] CAR-T cell therapy for hepatocellular carcinoma: current trends and challenges
    Zhou, Yexin
    Wei, Shanshan
    Xu, Menghui
    Wu, Xinhui
    Dou, Wenbo
    Li, Huakang
    Zhang, Zhonglin
    Zhang, Shuo
    FRONTIERS IN IMMUNOLOGY, 2024, 15